<DOC>
	<DOCNO>NCT00662194</DOCNO>
	<brief_summary>Data study provide first information innate immune system may alter HIV-HCV HIV-HBV co-infected individual , describe Toll-like receptor change HIV co-infection therapy .</brief_summary>
	<brief_title>Innate Immunity HIV Positive Patients Co-infected With Hepatitis C Virus ( HCV ) Hepatitis B Virus ( HBV )</brief_title>
	<detailed_description>It demonstrate Toll-like receptor ( TLR ) involve viral hepatitis - hepatitis B ( HBV ) , hepatitis C ( HCV ) - HIV set mono-infection . However role innate immunity pathogenesis HIV-hepatitis co-infection natural therapy-associated viral clearance remain unclear . The data study may reveal pattern could predict patient spontaneously , therapy , resolve HBV HCV set co-infection . The aim study evaluate activity innate immunity different subset HIV-infected population co-infected chronic hepatitis B and/or C. Our hypothesis innate immunity alter HIV hepatitis co-infection differs hepatitis HIV mono-infection . The study cross-sectional longitudinal pilot study individual infect HIV either HBV HCV .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Coinfection</mesh_term>
	<criteria>HIV either HBV HCV coinfection 18 year older able give inform consent HIVHBVHCV triple infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>HBV</keyword>
	<keyword>HCV</keyword>
	<keyword>co-infection</keyword>
	<keyword>innate immunity</keyword>
</DOC>